Vincerx Pharma Inc Stock News
$0.05
1.80%
yesterday
Nasdaq,
Oct 03, 08:07 pm CET
Vincerx Pharma Inc Stock News
Neutral
GlobeNewsWire
●
3 months ago
Revised Potential Distribution Range of $0.03 to $0.07 per share based on current estimates and assumptions
Neutral
GlobeNewsWire
●
3 months ago
Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely approval of Distribution Proposal
Neutral
GlobeNewsWire
●
4 months ago
Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholders Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholders
Neutral
GlobeNewsWire
●
6 months ago
Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025
Neutral
GlobeNewsWire
●
6 months ago
SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI, regarding a potential merger.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
